The original GeneSight test is exclusively a clinical test although the company now offers an at-home option. Depression or major depressive disorder.GeneSight markets its test for people who require treatments for conditions including: The GeneSight test focuses exclusively on analyzing gene-drug interactions to identify the best treatments for mental health conditions. GeneSight’s product is backed by seven peer-reviewed studies and clinical trials, including one study that showed higher remission rates among those who took the test.Īs a clinical pharmacogenomics test, it works differently than other DNA tests like 23andMe and AncestryDNA.
#DONE ADHD REVIEWS 2022 TRIAL#
This can help patients find the proper treatment and save months or years of a painful trial and error process to find effective medication for difficult conditions. The company offers DNA testing to better understand drug interactions for mental health conditions. Reports focus exclusively on genes relevant to psychotropic medications. In 2016, Myriad Genetics acquired Assurex Health, an informatics-based precision medicine company providing treatment decision support to healthcare professionals with mental health patients. GeneSight is a diagnostic DNA test from Myriad Genetics.
A lot of personal is collected and shared.More expensive than whole genome sequencing.Can save patients trial and error for selecting medications.Offers a diagnostic test with sign-off from doctors.Specifically tailored to psychiatric medication.
0 kommentar(er)
